Sabra CEO sells 200,000 shares at $20.83

Sabra’s chair and CEO reported a 200,000-share indirect sale under a Rule 10b5-1 trading plan while retaining over 1.6 million shares and additional stock units.

Rhea-AI Filing Summary

Sabra Health Care REIT, Inc. (SBRA) reported that Chair, CEO and President Richard K. Matros, through the R&A Matros Revocable Trust, sold 200,000 shares of common stock on September 8, 2026 at a weighted average price of about $20.83 per share under a Rule 10b5-1 trading plan adopted on June 8, 2026. After this sale, the trust held 1,657,686 shares of common stock, and Matros also held 956,268 stock units that will settle on a one-for-one basis in Sabra common stock.

Insider Trade Summary 10b5-1

Net Seller: 200,000 shares

Net Sell 2 txns

Insider MATROS RICHARD K

Role Chair, CEO and President

Sold 200,000 shs ($4.17M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	200,000	$20.83	$4.17M
holding	Common Stock F3	--	--	--

Holdings After Transaction: Common Stock — 1,657,686 shares (Indirect, By R&A Matros Revocable Trust); Common Stock — 956,268 shares (Direct)

Footnotes (3)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2026.
2. F2. The price report in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.66 to $20.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. Consists of stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Key Figures

Shares sold: 200,000 shares Weighted average sale price: $20.83 per share Sale price range: $20.66–$20.94 per share +3 more

6 metrics

Shares sold 200,000 shares Common stock sold on September 8, 2026 by R&A Matros Revocable Trust

Weighted average sale price $20.83 per share Average price for the 200,000 shares sold on September 8, 2026

Sale price range $20.66–$20.94 per share Range of prices for multiple transactions included in the 200,000-share sale

Indirect holdings after sale 1,657,686 shares Common stock held by R&A Matros Revocable Trust following the sale

Direct stock units held 956,268 stock units Stock units payable one-for-one in Sabra common stock upon settlement

Rule 10b5-1 plan adoption date June 8, 2026 Date Richard K. Matros adopted the trading plan used for this sale

Key Terms

Rule 10b5-1 trading plan, weighted average price, stock units

3 terms

Rule 10b5-1 trading plan regulatory

"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported is a weighted average price for shares sold in multiple transactions"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

stock units financial

"Consists of stock units that, upon settlement, will be paid on a one-for-one basis"

Stock units are individual pieces of ownership in a company, like slices of a pie that together make up the whole business. They matter to investors because each unit represents a claim on the company’s assets, profits and sometimes voting power, and changes in the number or value of these units affect ownership percentages, potential dividends and share dilution — all of which influence an investment’s worth.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SBRA shares did Richard K. Matros sell in this insider transaction?

Richard K. Matros, Sabra’s Chair, CEO and President, reported the sale of 200,000 shares of Sabra common stock on September 8, 2026 through the R&A Matros Revocable Trust.

What was the sale price per share in the SBRA insider transaction?

The reported price per share was a weighted average of $20.83. The disclosure states the shares were sold in multiple transactions at prices ranging from $20.66 to $20.94, inclusive.

Was the SBRA insider sale by Richard K. Matros under a Rule 10b5-1 plan?

Yes. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Richard K. Matros on June 8, 2026.

How many SBRA shares does the R&A Matros Revocable Trust hold after the sale?

After the reported sale, the R&A Matros Revocable Trust held 1,657,686 shares of Sabra common stock.

What direct SBRA holdings does Richard K. Matros report after this transaction?

He reports 956,268 stock units as a direct holding. These stock units, upon settlement, will be paid on a one-for-one basis in shares of Sabra’s common stock.

Is the SBRA insider sale characterized as direct or indirect ownership?

The 200,000-share sale involved shares held indirectly through the R&A Matros Revocable Trust, not shares held directly in Richard K. Matros’s own name.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/09/2026 - 07:03 PM Accepted by SEC EDGAR 09/09/2026 - 07:03 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MATROS RICHARD K

(Last) (First) (Middle)

C/O SABRA HEALTH CARE REIT, INC.

1781 FLIGHT WAY

(Street)

TUSTIN CALIFORNIA 92782

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sabra Health Care REIT, Inc. [ SBRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chair, CEO and President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/08/2026		S(1)		200,000	D	$20.83(2)	1,657,686	I	By R&A Matros Revocable Trust
Common Stock								956,268(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2026.

2. The price report in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.66 to $20.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Consists of stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Remarks:

	/s/ Michael Costa, as Attorney-in-Fact	09/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)